Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phas...

por Ruilope, Luis, Hanefeld, Markolf, Lincoff, A Michael, Viberti, Giancarlo, Meyer-Reigner, Sylvie, Mudie, Nadejda, Wieczorek Kirk, Dominika, Malmberg, Klas, Herz, Matthias
Publicado 2014